Cargando…
Hydroxypropyl chitosan nail lacquer of ciclopirox-PLGA nanocapsules for augmented in vitro nail plate absorption and onychomycosis treatment
Onychomycosis accounts for 90% of nail infections worldwide. Topical therapy provides localized effects with minimal adverse systemic actions, yet its effectiveness is limited by minimal drug permeation through the keratinized nail plate. Ciclopirox (CIX) is a FDA-approved broad-spectrum antimycotic...
Autores principales: | Gaballah, Eman Yahya, Borg, Thanaa Mohammed, Mohamed, Elham Abdelmonem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848413/ https://www.ncbi.nlm.nih.gov/pubmed/36372978 http://dx.doi.org/10.1080/10717544.2022.2144543 |
Ejemplares similares
-
Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer: A Review of Its Use in Onychomycosis
por: Piraccini, Bianca Maria, et al.
Publicado: (2020) -
Amorolfine vs. ciclopirox – lacquers for the treatment of onychomycosis
por: Tabara, Katarzyna, et al.
Publicado: (2015) -
Ciclopirox Hydroxypropyl Chitosan (CPX-HPCH) Nail Lacquer and Breathable Cosmetic Nail Polish: In Vitro Evaluation of Drug Transungual Permeation Following the Combined Application
por: Monti, Daniela, et al.
Publicado: (2022) -
Onychomycosis: Potential of Nail Lacquers in Transungual Delivery of Antifungals
por: Akhtar, Nida, et al.
Publicado: (2016) -
Optimization of Drug Permeation from 8% Ciclopirox Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers
por: Cutrín-Gómez, Elena, et al.
Publicado: (2020)